Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling.
about
Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer.Microarray-based RNA profiling of breast cancer: batch effect removal improves cross-platform consistency.Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation statusHereditary breast cancer: clinical, pathological and molecular characteristics.Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.Genotype/Phenotype correlations in patients with hereditary breast cancerApplication of RNAi-induced gene expression profiles for prognostic prediction in breast cancerRNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families.FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.Genomic medicine and risk prediction across the disease spectrum.DNA Repair Deficiency Is Common in Advanced Prostate Cancer: New Therapeutic Opportunities.Hereditary breast and ovarian cancer: new genes in confined pathways.The emerging role of homologous recombination repair and PARP inhibitors in genitourinary malignancies.The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting.Computational Investigation of Homologous Recombination DNA Repair Deficiency in Sporadic Breast Cancer.Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer.Altered expression of telomere-associated genes in leukocytes among BRCA1 and BRCA2 carriers.HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.Phenotypic characteristics of colorectal cancer in BRCA1/2 mutation carriers.Characterization of basal-like subtype in a Danish consecutive primary breast cancer cohort.Increased centrosome number in BRCA-related breast cancer specimens determined by immunofluorescence analysis.PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside.PARP inhibitors: the journey from research hypothesis to clinical approval.BRCA1/2 testing: therapeutic implications for breast cancer management
P2860
Q30491493-A9A6DA22-9767-4CC7-B0C3-C57087FFF123Q33914600-0B695D72-5F28-41EF-B13B-B2E7947ABF93Q34038170-89916948-037B-4967-BF77-2B3946CA2838Q34425230-CDBD0A85-1501-442C-AF87-C0CB0306945AQ35155449-1ABE7C7F-4B21-4DF5-A4A6-99B95515F97EQ35399541-FBA2322A-69DE-41AA-A406-C702A1A5F05AQ37374438-CC03EE41-309B-4C07-9EC7-8DE70FE10CF0Q37539804-0C0BA3C7-0F16-4016-9C5E-3D1F317D2CB2Q37689013-C2556C91-C31E-4F3E-B707-2627DB4315ECQ38322338-5476D1ED-8E55-435F-A487-007647FBA48EQ38851459-788AB4ED-EAED-4C38-A21F-13F569443011Q38925408-5E0F1165-BAEE-4DE4-8023-8A3A3121D31EQ39190147-D1352A6D-280B-40E8-AE34-8E7B3657175FQ41542872-DE0C642D-E9E6-45F6-ACDB-B1A6602B0710Q47145727-7BFC92A1-0038-4C77-AC2F-20A466255B1BQ47621328-E9D169F9-3638-4D09-99F0-E544EE1DB8D9Q47782009-1247A44E-53A6-4D55-91D6-F03FE5B02A80Q48134701-9D6C5EE8-92EB-4912-B6C9-C10B7FDC5DD0Q48266858-C82BB37E-4D75-4406-AB46-81B2824F4A3CQ49818569-B211A9A4-6709-4241-BD4B-F43A2FC2FFC3Q51758191-938D1A38-A23E-4F85-82A1-8A7BEC0BC02FQ52585367-BE01B771-C4CC-4B33-B430-F4605EBF40E7Q53682668-66F64710-2EE7-4BDB-BA8A-74EADC811BA0Q57110101-DBEDB113-175D-483D-99CC-6A61AFF41A4D
P2860
Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Classifications within molecul ...... rriers by RNA tumor profiling.
@ast
Classifications within molecul ...... rriers by RNA tumor profiling.
@en
Classifications within molecul ...... rriers by RNA tumor profiling.
@nl
type
label
Classifications within molecul ...... rriers by RNA tumor profiling.
@ast
Classifications within molecul ...... rriers by RNA tumor profiling.
@en
Classifications within molecul ...... rriers by RNA tumor profiling.
@nl
prefLabel
Classifications within molecul ...... rriers by RNA tumor profiling.
@ast
Classifications within molecul ...... rriers by RNA tumor profiling.
@en
Classifications within molecul ...... rriers by RNA tumor profiling.
@nl
P2093
P2860
P50
P1433
P1476
Classifications within molecul ...... rriers by RNA tumor profiling.
@en
P2093
Anne E Lykkesfeldt
Anne-Vibeke Lænkholm
Kristina P Sørensen
Mads Thomassen
Martin Bak
Martin J Larsen
Thomas V O Hansen
Torben A Kruse
P2860
P304
P356
10.1371/JOURNAL.PONE.0064268
P407
P577
2013-05-21T00:00:00Z